Jump to content
Powered by
  • BIOPRO BW
  • Healthcare industry
  • Bioeconomy

Healthcare industry

Main navigation

  • Start page
  • Healthcare industry BW

    Healthcare industry BW

    Close
    • At a glance
    • The biotechnology sector
    • Medical technology
    • The pharmaceutical industry
    • Training & university education
    • Company foundation
    • Infrastructure
    • Clusters & Networks
  • Articles

    Articles

    Close
    • Latest news
    • Selected press releases
    • Dossiers
    • Red biotechnology
    • Medical technology
    • Pharmaceutics
    • Diagnostics
    • Basic research
    • Selected publications
  • Events

    Events

    Close
  • Databases

    Databases

    Close
    • Funding
    • Healthcare industry database
    • Research institutions
  • BIOPRO services

    BIOPRO services

    Close
    • BIOPRO services and offers
    • Contacts
    • Information channels
  • de
  • en
Show menu

You are here:

  1. Home
  2. Search
Show:Results per page
  • 25Show results
  • 50Show results
  • 75Show results

Search Results

  • Press release - 07/10/2008

    GENEDATA SCREENER® – specialised data analysis for the identification of high-potential lead structures

    Genedata AG has developed a modular software system known as Genedata Screener that is tailored to screening and hit-to-lead applications. Dr. Timo Wittenberg who works at the companys site in Constance Germany told us about the advantages of the software for identifying high-potential leads.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/genedata-screener-specialised-data-analysis-for-the-identification-of-high-potential-lead-structures
  • Article - 06/10/2008

    Bacteria cells are highly organised

    Microbial cells long gave researchers the impression that they were in a state of complete disorder. Prof. Dr. Peter Graumann from the University of Freiburg investigates cell division in bacteria and knows that even microbes are highly organised.

    https://www.gesundheitsindustrie-bw.de/en/article/news/bacteria-cells-are-highly-organised
  • Article - 05/10/2008

    Award for AIDS researcher from Ulm

    The Dr. Ernst Wiethoff Award 2008 for innovative clinical research worth 25000 euros was presented to Jan Münch from the Institute of Virology at the University Hospital of Ulm. Münch discovered a new protein that blocks the HI virus.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/award-for-aids-researcher-from-ulm
  • Press release - 01/10/2008

    Virtual database screening saves time and money

    In order to be able to manage the growing amount of information in the life sciences the international research community has developed numerous electronic databases over the last few years. Supported by sophisticated software programmes the stored information can now be analysed effectively. In parallel with work-intensive screening methods which involve many laboratory experiments scientists are increasingly relying on computer-based methods.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/virtual-database-screening-saves-time-and-money
  • Press release - 30/09/2008

    Harald Krug is investigating the use of new materials

    Prof. Dr. Harald Krug a toxicologist who runs the Materials-Biology Interaction division at Empa - Swiss Federal Laboratories for Materials Testing and Research in St. Gallen Switzerland and his team are investigating the interactions of synthetic materials with biological systems. The team of 25 researchers is focusing in particular on the effect of particles and nanomaterials such as CNT on human and animal cells. The division has been an…

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/harald-krug-is-investigating-the-use-of-new-materials
  • Dossier - 29/09/2008 This computer-based picture shows a small blue and red coloured molecule that fits into a gap of a large grey molecule. Such molecular interactions are essential for pharmacological research.

    Drug screening - higher throughput, quicker and more effective thanks to automation

    Over the last few years automation has revolutionised the search for pharmaceutical compounds. Using methods such as high-throughput screening or high-content screening it is possible to analyse thousands of molecule activities very quickly.

    https://www.gesundheitsindustrie-bw.de/en/article/dossier/drug-screening-higher-throughput-quicker-and-more-effective-thanks-to-automation
  • Article - 22/09/2008

    Controlled suicide

    Professor Dr. Christoph Borner from the University of Freiburg and his team are investigating the molecular mechanisms of apoptosis. Their research also provides insights into the medical treatment of cells that do not want to die - cancer cells.

    https://www.gesundheitsindustrie-bw.de/en/article/news/controlled-suicide
  • Article - 22/09/2008

    Insight into the evolution of parasitism

    Scientists at the Max Planck Institute for Developmental Biology together with American colleagues have decoded the genome of the Pristionchus pacificus nematode. It consists of a large number of genes. The scientists gain insight into the evolution of parasitism.

    https://www.gesundheitsindustrie-bw.de/en/article/news/insight-into-the-evolution-of-parasitism
  • Article - 08/09/2008

    Research increases hope

    Duchenne muscular dystrophy DMD is a severe disease affecting boys characterised by rapid progression of muscle degeneration so that boys as young as 10 to 12 years of age have to use a wheelchair and leading to death in young men. In Germany about 2500 children and young adults suffer from DMD.

    https://www.gesundheitsindustrie-bw.de/en/article/news/research-increases-hope
  • Press release - 05/09/2008

    Thomas U. Mayer - research for aesthetes

    Mayers major interest is cell division which he sees as an interesting and also a beautiful aesthetic process. Prof. Dr. Thomas U. Mayer occupies the chair of molecular genetics at the University of Constance where he enjoys working in close contact with colleagues from the field of chemistry.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/thomas-u-mayer-research-for-aesthetes
  • Article - 30/08/2008

    Helpful toxins

    Sometimes a few nanogrammes of toxin are all that is needed to kill someone. Prof. Dr. Dr. Klaus Aktories from the Institute of Experimental and Clinical Pharmacy at the University of Freiburg is investigating why some bacterial toxins are so extremely toxic. Together with his team of researchers Aktories has identified the molecular mechanism of action of Clostridium difficile toxins.

    https://www.gesundheitsindustrie-bw.de/en/article/news/helpful-toxins
  • Press release - 28/08/2008

    Günther Schütz and the regulation of gene expression by nuclear receptors

    Professor Dr. Günther Schützs work on the cell- and development-specific gene regulation using nuclear receptors has led amongst other things to new insights into the steroid hormone-dependent early development and differentiation of the nervous system the molecular mechanisms of learning and the development and regulation of drug addiction. Schütz has now been appointed Helmholtz professor which will enable him to continue his work beyond…

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/guenther-schuetz-and-the-regulation-of-gene-expression-by-nuclear-receptors
  • Article - 26/08/2008

    Gregor Mirow new CEO of greenovation

    The primary objective of greenovation Biotech GmbH is the implementation of a stable production platform for the manufacture of glycoproteins for industrial pharmaceutical applications in accordance with GMP guidelines. Now Gregor Mirow succeeds Hans Bodo Hartmann as the new managing director.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/gregor-mirow-new-ceo-of-greenovation
  • Article - 26/08/2008

    Regulation through protein degradation

    Proteins that are involved in the development of an organism must be activated at the right time and then inactivated if no longer required. Scientists in Tübingen investigate the specific degradation of these proteins through specialised and highly selective systems of the cell.

    https://www.gesundheitsindustrie-bw.de/en/article/news/regulation-through-protein-degradation
  • Article - 25/08/2008 import_03396_de.jpg

    Markers that reveal the correct biological age

    Researchers at the University of Ulm have just identified a number of proteins that reveal the biological age of a person. These biomarkers might be used in medical applications to adapt the medical treatment of older people to their individual biological age.

    https://www.gesundheitsindustrie-bw.de/en/article/news/markers-that-reveal-the-correct-biological-age
  • Press release - 18/08/2008

    One third of all biopharmaceuticals get a "sugar coating"

    More than 50 of recombinant proteins are altered while they are being synthesized in the cells sometimes once and sometimes several times. Experts call these alterations post-translational modifications.

    https://www.gesundheitsindustrie-bw.de/en/article/news/one-third-of-all-biopharmaceuticals-get-a-sugar-coating
  • Press release - 02/08/2008

    Hölle & Hüttner - takeover of the share capital of INTAVIS AG

    Tübingen-based Hölle & Hüttner AG is taking over the entire share capital of Cologne-based INTAVIS Bioanalytical Instruments AG retroactively as of 1 January 2008. Both companies specialise in the development and marketing of systems for the automation of biochemical and molecular biological processes.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/hoelle-huettner-takeover-of-the-share-capital-of-intavis-ag
  • Article - 29/07/2008

    Frank Kirchhoff advances AIDS research by posing the right questions

    Frank Kirchhoff an AIDS researcher from Ulm has learnt to pose important questions and find the right answers during his post-graduate studies. This recipe has brought him and his research group international recognition and makes him one of the best AIDS researchers worldwide. Important publications within a very short time and numerous awards are clear evidence of his outstanding achievements. In addition he has just started a clinical trial…

    https://www.gesundheitsindustrie-bw.de/en/article/news/frank-kirchhoff-advances-aids-research-by-posing-the-right-questions
  • Article - 28/07/2008

    25 amino acids against avian influenza

    About a year ago Prof. Dr. Martin Schwemmle and his team at the University Hospital of Freiburg discovered a new starting point in the fight against the H5N1-virus. In the meantime the scientists are working together with the company Pike Pharma to develop a compound.

    https://www.gesundheitsindustrie-bw.de/en/article/news/25-amino-acids-against-avian-influenza
  • Article - 21/07/2008

    Basic plant research provides insights into cancer research

    Claus Schwechheimer at the Centre for Plant Molecular Biology at the University of Tübingen has succeeded in identifying a protein function in plants which if it is understood might lead to important progress in human cancer research.

    https://www.gesundheitsindustrie-bw.de/en/article/news/basic-plant-research-provides-insights-into-cancer-research
  • Article - 20/07/2008

    Vladimir Katanaev - key signals for embryos

    Dr. Vladimir Katanaev a biologist at Constance University is investigating an intracellular signalling pathway that is of decisive importance for the embryonic development of multicellular organisms. The Wnt-Frizzled signalling pathway also plays an important part in the development of cancer.

    https://www.gesundheitsindustrie-bw.de/en/article/news/vladimir-katanaev-key-signals-for-embryos
  • Article - 14/07/2008

    Rivalry amongst research groups - a thing of the past?

    The Membrane Proteins and Biological Membranes research training group combines research groups from Freiburg Basel and Strasbourg. Students from numerous countries benefit from the know-how of the diverse life sciences areas.

    https://www.gesundheitsindustrie-bw.de/en/article/news/rivalry-amongst-research-groups-a-thing-of-the-past
  • Article - 11/07/2008

    HMLS Prize for Heidelberg researchers

    Prof. Dr. Bernhard Eitel Rector of the University of Heidelberg awarded the HMLS Prize to Prof. Dr. Bernd Bukau Centre for Molecular Biology in Heidelberg and Prof. Dr. Hans-Georg Kräusslich Institute of Hygiene at the University of Heidelberg.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/hmls-prize-for-heidelberg-researchers
  • Article - 07/07/2008 Arabidopsis seedlings with different sizes

    Control centre for light and cold

    Plants grow well under optimal light conditions but only if they are not under stress. Cell biologists have long assumed that information is exchanged between the molecular signalling pathways that mediate light perception and stress tolerance.

    https://www.gesundheitsindustrie-bw.de/en/article/news/control-centre-for-light-and-cold
  • Article - 02/07/2008

    The cancer cells' sweet tooth might be their death sentence

    Cancer cells are dangerous foodies. They metabolise far greater amounts of sugar than healthy cells. Nuclear medicine experts make use of cancer cells craving for sugar since the advent of modern positron emission tomography PET. This has led to an improvement in the quality of cancer treatment.

    https://www.gesundheitsindustrie-bw.de/en/article/news/the-cancer-cells-sweet-tooth-might-be-their-death-sentence

Page 30 / 33

sb_search.block.search_result.other.pages

  • eine Seite vor
  • 1
  • …
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • eine Seite zurück
  • Extend search to all portals
  • Search the Healthcare industry database
  • Search the Research institutions
Search terms
Portal
Information type
  • Type
    Event date
    From
    To
  • Type
  • Publication date
    Topics
    Topics
  • Publication date
Reset

Footer navigation

  • Healthcare industry BW
    • At a glance
    • The biotechnology sector
    • Medical technology
    • The pharmaceutical industry
    • Training & university education
    • Company foundation
    • Infrastructure
    • Clusters & Networks
  • Articles
    • Latest news
    • Selected press releases
    • Dossiers
    • Red biotechnology
    • Medical technology
    • Pharmaceutics
    • Diagnostics
    • Basic research
    • Selected publications
  • Events
  • Databases
    • Funding
    • Healthcare industry database
    • Research institutions
  • BIOPRO services
    • BIOPRO services and offers
    • Contacts
    • Information channels
  • Project pages
    • Telemedicine BW
    • MDR & IVDR
  • Portals
    • BIOPRO BW
    • Healthcare industry
    • Bioeconomy
  • To top

stay informed

Subscribe to newsletter

Social Media

  • Xing
  • Twitter
  • LinkedIn
  • Rss
  • Privacy statement
  • Legal notice
  • Sitemap
  • Contact
© 2022
Website address: https://www.gesundheitsindustrie-bw.de/en/search